Sanofi (SNY) Total Non-Current Liabilities (2009 - 2026)

Sanofi has reported Total Non-Current Liabilities for 18 years, with the latest figure at $32.0 billion in Q2 2026.

• Quarterly Total Non-Current Liabilities rose 10.47% year-over-year to $32.0 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $32.0 billion (up 10.47% YoY) and the FY2025 annual result came in at $31.1 billion, up 13.04% from the prior year.
• Total Non-Current Liabilities rose to $32.0 billion in Q2 2026 per SNY's latest filing, from $31.1 billion in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $32.0 billion in Q2 2026 and troughed at $27.5 billion in Q4 2024.
• A 5-year average of $29.7 billion and a median of $30.0 billion in 2023 frame the typical range for Total Non-Current Liabilities.
• The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities fell 17.73% in 2022, then rose 13.04% in 2025.
• Over 5 years, Total Non-Current Liabilities stood at $28.2 billion in 2022, then increased by 6.64% to $30.0 billion in 2023, then decreased by 8.25% to $27.5 billion in 2024, then gained by 13.04% to $31.1 billion in 2025, then increased by 2.89% to $32.0 billion in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $32.0 billion, $31.1 billion, and $29.0 billion for Q2 2026, Q4 2025, and Q2 2025 respectively.